InsiderClue
Insiders · Profile

Bencherif Merouane

SVP, Preclinical Research at GYRE THERAPEUTICS. Filing since 27 Jul 2009. CIK 0001295831

Company
Date
Role
Action
Shares
Amount
Of holding
GYRE GYRE THERAPEUTICS, INC.
19 Jan 2011
SVP, Preclinical Research
Sold, plan not stated
30,203
$818.26K
100%
GYRE GYRE THERAPEUTICS, INC.
18 Jan 2011
SVP, Preclinical Research
Sold, plan not stated
22,800
$619.48K
100%
GYRE GYRE THERAPEUTICS, INC.
10 Dec 2010
SVP, Preclinical Research
Sold, plan not stated
32,093
$771.96K
100%
GYRE GYRE THERAPEUTICS, INC.
15 Jan 2010
VP, Preclinical Research
Sold, plan not stated
73,108
$1.50M
100%
GYRE GYRE THERAPEUTICS, INC.
4 Jan 2010
VP, Preclinical Research
Sold, plan not stated
7,735
$160.95K
100%
GYRE GYRE THERAPEUTICS, INC.
16 Dec 2009
VP, Preclinical Research
Sold, plan not stated
15,532
$340.66K
66.8%
GYRE GYRE THERAPEUTICS, INC.
15 Dec 2009
VP, Preclinical Research
Sold, plan not stated
8,056
$178.72K
51.0%
GYRE GYRE THERAPEUTICS, INC.
14 Dec 2009
VP, Preclinical Research
Sold, plan not stated
12,935
$290.37K
62.6%
GYRE GYRE THERAPEUTICS, INC.
28 Jul 2009
VP, Preclinical Research
Sold, plan not stated
41,213
$428.13K
84.2%
GYRE GYRE THERAPEUTICS, INC.
27 Jul 2009
VP, Preclinical Research
Sold, plan not stated
42,271
$428.72K
84.5%
10 decisions on file.